2022 American Transplant Congress
Evaluation of Diabetes-Free Life Expectancy Among Living Kidney Donors and Non-Donors with Obesity: A Longitudinal Cohort Study
*Purpose: The growing end stage kidney disease burden paired with substantial rates of obesity in the United States (US) has prompted increased approval of obese…2022 American Transplant Congress
Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection
1Virginia Commonwealth University, Richmond, VA, 2University of Alberta, Edmonton AB, AB, Canada
*Purpose: Chronic active antibody mediated rejection (cABMR) is a major cause of kidney transplant (KT) loss. Current therapies have unclear efficacy and side effects. We…2022 American Transplant Congress
Assessment of the Prevalence of Burnout and Well-Being in Solid Organ Transplant Pharmacists
*Purpose: The purpose of this study was to determine the prevalence of burnout and well-being among solid organ transplant pharmacists in the United States.*Methods: A…2022 American Transplant Congress
Impact of a Pharmacist on Transitions and Ambulatory Outcomes in Lung Transplant Recipients
*Purpose: Minimal data exists describing the impact of a pharmacist in transitions of care (TOC) and ambulatory medication management in lung transplant recipients (LTRs). Following…2022 American Transplant Congress
Selection of the Recipient Artery Used for Arterial Reconstruction in Living Donor Liver Transplantation: Does It Impact Biliary Reconstruction Outcomes
Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura, Egypt
*Purpose: Impact of level and laterality of the recipient hepatic artery used for arterial reconstruction in living donor liver transplantation on the outcomes of biliary…2022 American Transplant Congress
Clinical Evolution of Patients with De Novo DSA After Kidney Transplantation
*Purpose: De novo donor-specific antibodies(dnDSA) are related to antibody-mediated rejection(ABMR), but the evolution of patients after dnDSA is variable and not always ABMR and graft…2022 American Transplant Congress
Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes
Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA
*Purpose: Preoperative bland portal vein thrombosis (PVT) is common in Liver transplant (LT) candidates and has been suspected to negatively impact post-LT outcomes, however studies…2022 American Transplant Congress
Living Donor Kidney Transplant in Recipients with Glomerulonephritis: Donor Recipient Biologic Relationship and Allograft Outcomes
1Nephrology, University of Minnesota, Minneapolis, MN, 2MHealth, Minneapolis, MN
*Purpose: Controversies exist over the impact of donor-recipient biologic relationship on the outcomes of living donor kidney transplant in recipients with glomerulonephritis (GN). The improved…2022 American Transplant Congress
Renal Graft Outcomes in Simultaneous Heart-Kidney Transplantation
Westchester Medical Center / New York Medical College, Valhalla, NY
*Purpose: Simultaneous heart and kidney transplantation (SHKT) has increased steadily in United States Previously it was shown that SHKT is associated with benefits in overall…2022 American Transplant Congress
Prescription Opioid Use May be More Detrimental to Younger Kidney Transplant Recipients: A Machine Learning Approach
1Johns Hopkins, Baltimore, MD, 2Saint Louis University, St. Louis, MO
*Purpose: Prescription opioid use requires special attention in kidney transplant (KT) recipients considering that it increases the risk of death and graft loss. However, the…
- « Previous Page
- 1
- …
- 61
- 62
- 63
- 64
- 65
- …
- 1683
- Next Page »